Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Vet Ophthalmol. 2010 Jul;13(4):211–218. doi: 10.1111/j.1463-5224.2010.00782.x

Figure 8.

Figure 8

Quantitative real-time PCR reactions showing measurements of α-SMA in MMC treated or untreated ECF. TGFβ1 exposure induced significant α-SMA formation in ECF and early MMC treatment significantly decreased TGFβ1-induced myofibroblast formation in ECF. Late MMC treatment showed moderate decrease in α-SMA RNA (data not shown). ¬indicates p <0.01 (Con vs TGFβ1) and * represents p<0.01 (TGFβ1 vs TGFβ1+MMC early).